Eikon Therapeutics, Inc. Common Stock (EIKN) Stock Forecast
Data as of Aug 8, 2026Healthcare · Current price $9.38 (+1.90%)
Consensus Target
$5.00
Upside
-46.7%
Analysts
2
Rating
Sell(4.00)
Price Target Range
Low $5.00High $5.00
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
Consensus
Sell
Strong Buy0
Buy0
Hold0
Sell1
Strong Sell0
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
No analyst price targets available.
EIKN vs Sector & Market
| Metric | EIKN | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 4.00 | 2.25 | 2.42 |
| Analyst Count | 2 | 8 | 18 |
| Target Upside | -46.7% | +16286.5% | +14.7% |
| P/E Ratio | -3.55 | 3.59 | 36.06 |
Frequently Asked Questions
What is the analyst consensus for EIKN?
The consensus among 2 analysts covering Eikon Therapeutics, Inc. Common Stock (EIKN) is Sell with an average price target of $5.00.
What is the highest price target for EIKN?
The highest analyst price target for EIKN is $5.00.
What is the lowest price target for EIKN?
The lowest analyst price target for EIKN is $5.00.
How many analysts cover EIKN?
2 analysts have issued ratings for Eikon Therapeutics, Inc. Common Stock in the past 12 months.
Is EIKN a buy or sell right now?
Based on 2 analyst ratings, EIKN has a consensus rating of Sell (4.00/5) with a -46.7% upside to the consensus target of $5.00.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.